Scaling Up the Health Response to Climate Change: Highlights from the World Health Organization Executive Board’s 156th Meeting on the Global Action Plan on Climate Change and Health
By Bianca Carvalho
The Executive Board of the World Health Organization (WHO), during its 156th meeting held from 3-11 February 2025, discussed a draft Global Action Plan on Climate Change and Health (2025 – 2028) (EB156/40). This policy brief explains the content of the draft Global Action Plan and summarises the feedback provided by Member States during the Executive Board meeting.
Member States at the 156th WHO Executive Board meeting made recommendations for the Global Action Plan, including to ensure that equity remains central, to foster collaboration across sectors, and to enhance support mechanisms—both technical and financial—for developing countries addressing the intersection of climate change and health challenges. Member States also called for more consultations before the draft Global Action Plan is considered for adoption at the 78th World Health Assembly in May 2025.
Statement of the Executive Director of the South Centre, Dr. Carlos Correa, at the NAM Health Ministers’ Meeting on the sidelines of the 78th World Health Assembly (May 19-27, 2025)
The decisions to be made at the 78th World Health Assembly will have direct implications not only for national health systems, but also for the very architecture of international cooperation in health. Read the statement by the Executive Director of the South Centre, Dr. Carlos Correa, at the NAM Health Ministers’ Meeting on the sidelines of the 78th WHA.
Gender Intersectionality in Antimicrobial Resistance
Date & Time: 14 May 2025, 4PM CET Geneva time / 10AM EST / 2PM GMT
Key Discussion Points:
The intersectionality of gender with other social determinants (e.g. socioeconomic status, education, occupation) in shaping AMR vulnerabilities and outcomes.
How gender influences antibiotic use, access to healthcare, and infection prevention and control practices?
Strategies for integrating gender-sensitive approaches into AMR policies, programs, and research
Leaving the WHO? The US Just Shot Itself in the Foot
By Germán Velásquez
At the start of his second term, United States president Donald Trump has again announced that the US will formally leave the World Health Organization (WHO) in 2025. Leaving the WHO is a financial blow to the Organization, as many have pointed out, but it is much more than that. Trump’s decision to abandon WHO is counterproductive and puts at risk the capacity of the organization to perform its role as the global health agency. The WHO has been central to responding to global health emergencies for more than seven decades. Its work in the fight against diseases such as smallpox, polio, Ebola and HIV/AIDS, or the binding international convention against tobacco use, has saved millions of lives.
The US’ withdrawal from WHO will have a serious impact on various aspects of global health, and the US will itself be directly affected. WHO members should unite to strengthen the WHO and counteract this decision by the current US Administration.
The South Centre is seeking to fill a consultancy position to support its activities in the area of tackling antimicrobial resistance in developing countries.
The Consultant will be engaged on a full or part-time basis by the South Centre under a Special Service Agreement (SSA) for a period of 6 months.
The place of assignment is Geneva, Switzerland, or from a remote location.
Advancing Women’s, Children’s and Adolescents’ Health and Inequalities in Sexual, Reproductive, Maternal, Newborn, Child and Adolescent Health:
Highlights from the 156th Meeting of the World Health Organization’s Executive Board
By Bianca Carvalho, Viviana Munoz Tellez
This policy brief examines discussions from the WHO’s 156th Executive Board meeting (February 2025) on the Global Strategy for Women’s, Children’s and Adolescents’ Health. The Director-General reported many countries falling behind on SDG targets for maternal and child mortality, with persistent inequalities in healthcare access. Member States emphasized the urgent need to accelerate progress through universal access to comprehensive sexual and reproductive health services and rights, including the right to make informed decisions about reproduction free from discrimination, coercion, and violence. Recommendations focused on priorities for updating the Global Strategy and increasing investments. Two resolutions were advanced: one on regulating digital marketing of breast-milk substitutes (proposed by Brazil and Mexico) and another on World Prematurity Day (proposed by Tanzania). These will be considered for adoption by the World Health Assembly in May 2025.
Advancing Women and Girls’ Health in a Time of Converging Crises
Date: 24 April 2025
Time: 14:30 to 16:30 PM
Venue: Maison de la Paix, Petal 2, Room S12, Eugène-Rigot 2, Geneva, Switzerland
The global community faces unprecedented challenges in realising the right to health for all. While progress towards the Sustainable Development Goals (SDGs) acknowledges the importance of gender equality and sexual and reproductive health and rights (SRHR), this progress is threatened by persistent inequalities, the lingering effects of the COVID-19 pandemic, escalating climate change impacts, ongoing conflicts, and socio-economic disparities. These converging crises disproportionately affect vulnerable populations, exacerbating marginalisation and hindering progress towards achieving universal health coverage, with particularly severe consequences for women and girls.
This briefing aims to provide a comprehensive overview of these challenges and propose concrete strategies to advance SRHR within international cooperation and the SDGs. The South Centre will host this briefing to foster policy dialogue on how States can fulfil their obligations to advance the right to health for all, with a central focus on SRHR.
Human Rights Council 58: Neurotechnology, Ethical Frontiers and Human Rights
By Daniel Uribe
The UN Human Rights Council’s 58th session examined the impact of neurotechnology on human rights, with a particular focus on privacy. The Special Rapporteur guided discussions on the report on neurotechnology, which detailed risks to privacy, autonomy, and mental integrity, and proposed principles such as human dignity, informed consent, stringent security measures, rights-by-design, and precautionary approaches to the development of this technology. This SouthViews considers the Member States’ discussion during the presentation of this report, taking into account the profound ethical challenges, the need for safeguards, equitable access (especially for developing nations), and international cooperation, while voicing concerns about potential misuse. The relevance of UNESCO’s ongoing work on the ethics of neurotechnology is also considered. The session underscored the pressing need for a proactive, holistic, and ethically grounded governance framework for neurotechnology, emphasizing core human rights principles and international collaboration to ensure the responsible development and use of this technology.
South Centre Statement to the Resumed Thirteenth Meeting of the Intergovernmental Negotiating Body to Draft and Negotiate a WHO Convention, Agreement or Other International Instrument of Pandemic Prevention, Preparedness and Response
7 April 2025
Negotiations resume for a WHO pandemic agreement, aiming to finalise the text in 5 days. Will Member States show the needed leadership and will to deliver an impactful outcome with equity at the core?
Strengthening Antimicrobial Stewardship Policy: Insights from COVID-19 and Future Pandemic Preparedness
South Centre Webinar
Date: 14 April 2025 Time: 12:00 PM – 1:00 PM CEST | 6:00 AM – 7:00 AM EDT | 3:30 PM – 4:30 PM IST Location: Virtual (Zoom)
In this one-hour webinar, we will explore how the COVID-19 pandemic impacted antimicrobial stewardship (AMS) programmes and what lessons can strengthen future pandemic preparedness, especially in low- and middle-income countries (LMICs).
